How many insider declarations does 현대약품 have?

현대약품 has filed 1 insider declaration with DART (FSS).

Who is the top reporting insider at 현대약품?

The top reporting insider at 현대약품 is 신풍제약, based on the count of public filings.

Across the available history, declared buys total 0 and disposals 0.

FY ended November 2025 · cache

7590.00 €

Analyst consensus

·

Income statement

Revenue191.79 Bn€

Gross profit79.60 Bn€42% margin

Net income2.52 Bn€1.3% margin

Valuation

Beta0.84

Balance sheet & cash

Market cap198.37 Bn€

Total debt49.93 Bn€

Free Cash Flow−5.99 Bn€

Debt / Equity21%

Profitability & ownership

ROE1.5%

ROA0.9%

% insiders31.5%

% institutions0.3%

Last declaration on 4 March 2026